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ABSTRACT A Mr 32,000 integral membrane protein has
previously been identified on erythrocytes bearing the Rh(D)
antigen and is thought to contain the antigenic variations
responsible for the different Rh phenotypes. To study it on a
biochemical level, a simple large-scale method was developed to
purify the M, 32,000 Rh protein from multiple units of
Rh(D)-positive and -negative blood. Erythrocyte membrane
vesicles were solubilized in NaDodSO4, and a tracer of immu-
noprecipitated 1"I surface-labeled Rh protein was added. The
Rh protein was purified to homogeneity by hydroxylapatite
chromatography followed by preparative NaDodSO4/PAGE.
Approximately 25 nmol of pure Rh protein was recovered from
each unit of Rh(D)-positive and -negative blood. Rh protein
purified from both Rh phenotypes appeared similar by one-
dimensional NaDodSO4/PAGE, and the N-terminal amino
acid sequences for the first 20 residues were identical. Rh
proteins purified from Rh(D)-positive and -negative blood were
compared by two-dimensional iodopeptide mapping after 'DI-
labeling and a-chymotrypsin digestion. The peptide maps were
very similar; however, at least two additional iodopeptides
were consistently noted in the Rh proteins purified from
Rh(D)-positive erythrocytes. These data indicate that a similar
core Rh protein (or group of related proteins) exists in both
Rh(D)-positive and -negative erythrocytes, and the Rh proteins
from erythrocytes with different Rh phenotypes contain dis-
tinct structural polymorphisms.
The human erythrocyte Rh blood group antigens and anti-
bodies are ofmajor clinical significance (for reviews, see refs.
1-3). In addition to being a large concern in transfusion
medicine, Rh-specific antibodies have been implicated in
most cases of hemolytic disease of the newborn and in many
cases of autoimmune hemolytic anemia. The Rh blood group
system is complex, and molecular understanding of this
system has developed slowly. It remains uncertain whether
the major Rh antigen (D) and the minor Rh antigens (C/c and
E/e) are the products of a single gene (4) or multiple closely
linked genes (5).
Major advances have resulted from the identification of a
Mr 32,000 integral membrane protein on erythrocytes bearing
the Rh(D) antigen. This protein (referred to hereafter as the
"Rh protein") can be labeled on the extracellular surface of
the erythrocyte membrane with 1251I and can be immunopre-
cipitated with Rh(D) immunoglobulin (6, 7). The Rh protein
was found to contain no detectable carbohydrate (8) and is
linked to the erythrocyte membrane skeleton (9, 10). The Rh
protein can be disassociated from the membrane skeleton
under more stringent conditions (11), and no cytoplasmic
domain has been detected (12). Digestion of intact erythro-
cytes with high concentrations of proteases or glycosidases
will destroy the surface domains of other erythrocyte mem-
brane proteins, yet the Rh(D) protein survives (8, 12).
Reports describing the purification of small amounts of the
Rh protein have recently appeared (11, 12). Several questions
remain unanswered with regard to the relationship between
the purified Rh protein and the Rh antigen on the intact
membrane. Because of its limited solubility, it has been
impossible to reinsert the purified Rh protein into lipid
vesicles with immunologic restoration of the Rh antigen.
While Rh immunoglobulin reacts avidly with Rh antigen on
intact membranes, it fails to react specifically with Rh protein
or other membrane components on immunoblots (12). If the
Rh protein is the major constituent of the Rh antigen, there
should be inherent biochemical differences in the Rh protein
purified from erythrocytes of different Rh phenotypes. De-
termination of amino acid sequence of the Rh protein may
ultimately permit molecular genetic analysis of this complex
blood group system. Purification of larger amounts of the Rh
protein will therefore be essential for molecular understand-
ing of Rh biology.
MATERIALS AND METHODS
Purification of Rh Protein. Methods were derived from
those described by Bennett (13) for large-scale preparation of
membranes. Human blood was provided by the Johns Hop-
kins Hospital Blood Bank and the American Red Cross. Each
preparation was begun with 1 full unit ofhuman erythrocytes,
and the quantity of membranes at each stage of isolation
corresponds to this original volume of packed erythrocytes.
The packed erythrocytes were filtered through a Sepacell
R-500 leukocyte removal filter (Fenwal) and washed free of
plasma and platelets in phosphate-buffered saline. Whole
erythrocyte membranes were prepared by repeatedly lysing
and washing in 7.5 mM sodium phosphate, pH 7.4/1 mM
sodium EDTA/0.2 mM phenylmethylsulfonyl fluoride at 0C
with a Pellicon cassette system blood lysis apparatus (Milli-
pore). Spectrin and actin were extracted from whole mem-
branes by incubation in 10 vol of 0.2 mM sodium EDTA, pH
8.0/0.2mM phenylmethylsulfonyl fluoride for 30 min at 37°C,
and the membrane vesicles were pelleted by centrifugation at
30,000 x g in a Beckman J-14 rotor for >6 hr at 4°C. The
membrane pellet was vesiculated by drawing through a
19-gauge syringe needle and further stripped of all peripheral
membrane proteins by incubation in 10 vol of 1 M KI/7.5 mM
sodium phosphate, pH 7.4/1 mM sodium EDTA/1 mM
dithiothreitol/0.2 mM phenylmethylsulfonyl fluoride for 30
min at 37°C. The KI-stripped membrane vesicles were
pelleted at 30,000 x g for 5 hr at 4°C, washed again with the
same buffer once, and washed finally with 7.5 mM sodium
phosphate, pH 7.4/1 mM dithiothreitol/1 mM NaN3. The
vesicle pellet was solubilized in 100 ml of 1.2% (wt/vol)
NaDodSO4/7.5 mM sodium phosphate, pH 7.4/1 mM
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dithiothreitol/1 mM NaN3 by incubation for 1 hr at room
temperature followed by filtration through 0.2-pum mem-
branes (Millipore).
The tracer 1251I-labeled Rh protein was prepared by surface
labeling whole Rh(D)-positive erythrocytes with carrier-free
Nal25I (Amersham) in vials coated with Iodo-Gen (Pierce)
followed by immunoprecipitation with Rh(D) immunoglobu-
lin (Connaught Laboratories, Willowdale, Ontario) and pre-
parative NaDodSO4/PAGE as described (12). Approxi-
mately 25,000 cpm of the 1251I-labeled Rh protein <0.1 ,ug of
protein) was added to the solubilized vesicles.
The material was absorbed onto a column (2.5 x 62 cm)
packed with high resolution hydroxylapatite (Calbiochem)
that had previously been equilibrated with 0.2% (wt/vol)
NaDodSO4/7.5 mM sodium phosphate, pH 7.4/1 mM
dithiothreitol/1 mM NaN3 at a flow rate of 50 ml/hr while
8-ml fractions were collected (Fig. 1). The column was eluted
with 0.3 M (peak I) and 0.5 M sodium phosphate (peak II)
prior to elution with a 500-ml gradient of 0.5 to 0.8 M sodium
phosphate in the same buffer while optical absorbance at 280
nm and 125I radioactivity were monitored.
Fractions containing the peak and trailing side of the Rh
protein were combined, dialyzed against the running buffer,
and concentrated by shaking the dialysis bag in powdered
polyethylene glycol (Carbowax, PEG 8000; Fisher). The
contents of the bags were electrophoresed through 0.3 x 14
x 14 cm preparative 12% NaDodSO4/polyacrylamide gels
(Bio-Rad reagents) with the Laemmli buffer system (14). The
gels were cut into narrow strips, assayed for 125I, and the
peak fractions were eluted with running buffer by gently
shaking for 2 days at room temperature. The Mr 32,000 Rh
protein was identified at each stage of isolation by silver
staining analytical NaDodSO4/polyacrylamide gels.
Amino Acid Sequencing. Approximately 30 ,g of purified
Rh proteins was precipitated with chilled ethyl alcohol.
Determination of N-terminal amino acid sequences was
performed in the Johns Hopkins Protein/Peptide Facility in
the Department of Biological Chemistry with the Applied
Biosystems gas-phase protein sequencer (model 470A) cou-
pled to an on-line PTH analyzer (model 120A).
Two-Dimensional Iodopeptide Maps. Methods were de-
rived from those of Elder et al. (15). Approximately 10 ,ug of
purified Rh protein was precipitated in acetone ( - 20°C) and
resolubilized by incubation for 1 hr at 37°C in 30 ,ul of 6%
(wt/vol) NaDodSO4/50 mM sodium phosphate, pH 7.4. The
material was labeled with 1 mCi of carrier-free Na125I (1 Ci
= 37 GBq) after oxidation with chloramine T (Kodak) as
described (16). Approximately 50% of the radioactivity was
incorporated when assessed by precipitation with trichloro-
acetic acid. The contents of each tube were run out on 12%
NaDodSO4/polyacrylamide gels and the radioactive spots
corresponding to the '25I-labeled Rh protein were visualized
by autoradiography. Slices containing the 125I-labeled Rh
protein were excised, transferred to siliconized tubes, and
washed extensively first with 25% isopropyl alcohol and then
with 10% methyl alcohol. The slices were lyophilized and
incubated at 37°C in 2.0 ml of 50 mM NH4HC03 containing
100 ,ug of a-chymotrypsin (Cooper, Malvern, PA) for 15 hr.
An additional 100 ,ug of a-chymotrypsin was added and the
incubation was allowed to proceed for 9 hr more before the
contents were lyophilized, redissolved in electrophoresis
buffer (acetic acid/formic acid/water; 15:5:80), spotted on
20-cm cellulose thin-layer chromatogram sheets (Kodak),
and electrophoresed at 1000 V for 45 min. The second
dimension of separation was by thin-layer chromatography in
butyl alcohol/pyridine/acetic acid/water (80:53:12:55). The
dried plates were exposed to autoradiograph film.
RESULTS
Purification of the Rh Protein. Erythrocyte membranes
were stripped of spectrin, actin, and other proteins, and the
resulting membrane vesicles were further stripped of all
peripheral membrane proteins by incubation in 1 M KI (13).
These vesicles retain only proteins that penetrate the lipid
bilayer (integral membrane proteins) including the glycopho-
rins, the anion transporter, and the Rh protein (12). Because
of the limited solubility of the Rh protein, the vesicles were
solubilized in NaDodSO4. Since the surface antigenicity is
lost after solubilization of membranes, the Rh protein was
followed during purification by adding a radiolabeled tracer
of Rh protein immunoprecipitated from 125I surface-labeled
Rh(D)-positive erythrocytes with Rh(D) immunoglobulin
(12).
The solubilized material was adsorbed onto a hydroxylap-
atite column and eluted with a sodium phosphate gradient
(Figs. 1 and 2). The glycophorins (peak I) and the bulk of the
anion transporter (peak II) eluted early. The elution behavior
of the Rh protein was unique and constituted the majority of
the protein eluted at the high end of the sodium phosphate
gradient (fractions IIIB-D), although a small amount ofanion























FIG. 1. Purification of the Rh protein by hydroxylapatite chromatography. Erythrocyte membrane vesicles from 1 unit of blood were
solubilized in NaDodSO4 and combined with a tracer of 125I surface-labeled Rh protein. The material was loaded onto a hydroxylapatite column
and eluted with sodium phosphate gradients while monitoring for optical absorbance at 280 nm and 125I radioactivity. Contaminating membrane
proteins were eluted at the lower sodium phosphate concentrations (peaks I and II), and a third protein peak (III) was eluted by the 0.5-0.8
M sodium phosphate gradient. The bulk of the 125I-labeled Rh protein (fractions B and C) trailed after the major protein in peak III.
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FIG. 2. Stages of the purification analyzed by 12% NaDodSO4/
PAGE after staining with silver reagent. Numerals on left indicate
relative M, x 10-3. Lanes: 1, whole erythrocyte membranes; 2,
KI-extracted membrane vesicles. Remaining lanes refer to fractions
from Fig. 1: lane 3, peak I; lane 4, peak II; lane 5, fraction IIIA; lane
6, fraction IIIB; lane 7, fraction IHIC; lane 8, fraction IIID; lane 9,
pure Rh protein from fractions IIIB-D eluted from preparative
NaDodSO4/PAGE.
purified to homogeneity by elution from preparative NaDod-
S04/polyacrylamide gels (Fig. 2). Stages of a typical purifi-
cation are shown in Table 1. Approximately 740 pug of pure
Rh protein (20-25 nmol) was purified from a unit of blood,
and this represented a yield of -49%, based on recovery of
the tracer of 125I-labeled Rh protein. Similar recoveries were
noted in purifications ofRh protein from 8 units ofblood from
different Rh(D)-positive individuals. Evidence for purity of
the isolated Rh protein includes the following: (t) A single
band was seen on silver-stained NaDodSO4/polyacrylamide
gels. (ii) Aberrant migration of the single band was noted on
gels of higher acrylamide concentration (data not shown; see
also refs. 8 and 12). (iii) A single N-terminal amino acid
sequence was identified (see below). It cannot be determined,
however, whether the purified material is a mixture of nearly
identical isoforms of the Rh protein.
Puriflication of Rh Protein from Rh(D)-Negative Erythro-
cytes. It was uncertain whether a protein comparable to the
Rh protein would exist in Rh(D)-negative erythrocytes.
Therefore, purification of the Rh protein was followed with
a tracer of 1251-labeled Rh protein immunoprecipitated from
Rh(D)-positive erythrocytes. This method was used to purify
the Rh protein from 5 units of blood from different Rh(D)-
negative individuals. The yields from all Rh(D)-positive and
-negative preparations were quantitatively similar (600-800
mg per unit of blood), and analysis by one-dimensional
Table 1. Purification of Rh protein from 1 unit of blood
Relative
Protein, Recovery Purification, purity,
Step mg 125i, % -fold %
Whole membranes 700
Membrane vesicles 220 100 3.2
Hydroxylapatite 16 54 24.4 50
Preparative
NaDodSO4/PAGE 0.74 19 180 >95
Protein determinations were performed by the method ofLowry et
al. (17), with appropriate buffer controls and bovine serum albumin
used as standards. Relative purity was determined by densitometric
scanning of NaDodSO4/polyacrylamide gels stained with silver
reagent.
NaDodSO4/PAGE demonstrated a heavy band at M, 32,000
in each purification (Fig. 2).
N-Terminal Amino Acid Sequence of Purified Rh Proteins.
The Rh proteins purified from pooled Rh(D)-negative eryth-
rocytes obtained from four different individuals (probable
genotypes cde/cde) were subjected to amino acid sequenc-
ing. Rh proteins purified from pooled Rh(D)-positive eryth-
rocytes obtained from two individuals (probable genotypes
CDe/cDE) were processed similarly. The N-terminal amino
acid sequences were obtained up to the 20th residues, and the
sequences of both preparations were identical: Ser-Ser-Lys-
Tyr-Pro-Arg-Ser-Val-Arg-Arg-Xaa-Leu-Pro-Leu-Trp-Ala-
Leu-Thr-Leu-Glu. When compared to the computer-based
sequence library, it was found that this represents a unique
amino acid sequence with no closely related amino acid
sequences yet identified.
The initial amino acid recoveries obtained from sequencing
the purified Rh(D)-negative protein were >90% of the antic-
ipated values, but recoveries from sequencing the purified
Rh(D)-positive protein were only 40%. It is uncertain
whether the lower recovery is the result of a partial N-
terminal block due to damage inflicted during isolation or a
naturally occurring partial N-terminal block. Nevertheless,
for each preparation, serine was unambiguously identified in
the first two cycles with other amino acids accounting for
<5% of the initial signal. Recoveries gradually diminished
with each subsequent cycle to approximately half of the
original recovery by the 20th cycle. The fact that unblocked
N-terminal serines were identified suggests that the Rh
proteins were derived from a larger protein by proteolytic
cleavage after insertion into the lipid bilayer.
Comparison of Two-Dimensional Iodopeptide Maps. Rh
proteins purified from the Rh(D)-positive and -negative
erythrocytes were precipitated with cold acetone, labeled to
high specific radioactivity with 125I, and digested with a-
chymotrypsin (15). The iodopeptides were compared in two
dimensions by electrophoresis followed by thin-layer chro-
matography (Fig. 3). The two-dimensional iodopeptide maps
of Rh proteins purified from Rh(D)-positive and -negative
erythrocytes were very similar, with approximately one
dozen iodopeptides appearing to be identical. At least two
additional iodopeptides were identified in maps of Rh pro-
teins purified from Rh(D)-positive erythrocytes. Two distinct
iodopeptides were noted (nearest the center of the peptide
map), and two less distinct peptides were also detected (at the
far right of the peptide map). The two central iodopeptides
appear highly specific for Rh proteins from Rh(D)-positive
erythrocytes and have been seen in every iodopeptide map of
all preparations from Rh(D)-positive erythrocytes obtained
from eight individuals but have never been noted in prepa-
rations from Rh(D)-negative erythrocytes obtained from five
individuals.
DISCUSSION
It is likely that information derived from analysis of the Rh
protein may lead to a clearer molecular understanding of the
Rh antigen. The method described in this study will permit
the isolation of large amounts ofRh protein in pure form. This
method is much simpler than that recently reported for
purification of Rh protein beginning with membrane skele-
tons, and the yields are -8-fold larger (12). The Rh protein
has recently been purified on a smaller scale by monoclonal
antibody immunoprecipitations (11), and sequence analyses
of those preparations agree with that reported here (18). Such
large-scale purifications will be needed to provide sufficient
pure Rh protein to permit biochemical analysis of possible
posttranslational modifications and for generation of internal
peptide fragments to obtain internal amino acid sequences.
Additional sequences may be very important for develop-
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FIG. 3. Rh proteins purified from Rh(D)-negative (cde/cde; Left) and -positive (CDe/cDE; Center) erythrocytes ere compared by
two-dimensional iodopeptide mapping. The composite drawing (Right) identifies peptides shared by Rh proteins from both sources (open
figures). Four peptides are identified that are unique to Rh protein purified from Rh(D)-positive erythrocytes (solid figures), and a single peptide
was found partially reduced in Rh protein from Rh(D)-positive erythrocytes (hatched figure).
ment of the oligonucleotide probes needed for isolating the
Rh cDNA, since most of the sequence reported here contains
amino acids for which the genetic code is most degenerate.
Isolation of the Rh cDNA will be very desirable, since
ultimate determination of the complete amino acid sequence
of the Rh antigens will very likely require molecular genetic
analyses. Despite four and one-half decades of investigation,
it remains uncertain whether the Rh C/c, D, and E/e antigens
are the products of a single gene (4) or multiple closely linked
genes (5). Existence of d, the antithetical antigen to Rh(D), is
speculative and has never been confirmed. It remains to be
determined whether the Rh protein purified in these studies
is composed ofa single protein with multiple surface epitopes
or a mixture of distinct C, c, D, E, and e proteins. There
appears to be only a single protein band of Mr =32,000, and
the amino acid sequences were unambiguous. Therefore, if
multiple distinct protein species are present, they must be
very similar: identical N termini, nearly identical molecular
weights, and identical elution behavior from hydroxylapatite.
Immunoprecipitations from 1251I surface-labeled erythrocytes
with antibodies specific for c, D, or E, resulted in isolation of
similar Mr 30,000 proteins with differences in specific radio-
activities (6). Very recent work (19) indicates that immuno-
precipitated c and E proteins are slightly larger (Mr, 33,100)
than the D protein (Mr, 31,900), and one-dimensional iodo-
peptide maps of immunoprecipitated Rh c, D, and E proteins
indicate that they are similar, but not identical (18). These
observations suggest that the C/c, D, and E/e antigens may
be variations ofthe same gene product that results either from
gene duplication or alternate splicing of mRNA leading to
regions of nonidentity. There are at least two possible
explanations for the apparent absence of certain iodopeptides
from Rh(D)-negative preparations without the appearance of
new iodopeptides. (i) There may be point mutations where
tyrosines are -replaced by other amino acids. (it) There may
be alternate splicing ofmRNA with exons containing tyrosine
being replaced by exons lacking tyrosine.
Explanation of a possible physiologic role for the Rh
protein has yet to be established. A rare group of individuals,
described as "Rh null," lack all Rh antigens on their
erythrocytes; C, c, D, E, e, and Rh29 are not detected (20).
The erythrocytes from these patients are abnormally shaped
and fragile. It is thought that the Rh antigen may therefore
have a structural role. Identification of the structural asso-
ciation of the Rh protein with the membrane skeleton
suggests that it may be involved in a secondary form of
linkage of the skeleton to the lipid bilayer (9, 10). The
phospholipid asymmetry of the bilayer is lost from the
membranes of the Rh null erythrocytes (21), and a variety of
ion leaks have also been detected (22). Direct involvement
of the Rh protein in maintenance of phospholipid asymmetry
and the appropriate lipid milieu for ion transporters and
channels have been considered as other potential roles of the
Rh protein. The identification of nonerythroid analogs to all
other erythrocyte structural proteins suggests that analogs to
the Rh protein (which may lack the surface antigenic com-
ponent) may also exist and could be identified with Rh cDNA
probes.
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